Nymox Pharmaceutical Corporation (NYMXF)
OTCMKTS · Delayed Price · Currency is USD
0.1095
+0.0390 (55.32%)
At close: Mar 26, 2026
Nymox Pharmaceutical Market Cap
Nymox Pharmaceutical has a market cap or net worth of $7.19 million as of March 26, 2026. Its market cap has decreased by -30.82% in one year.
Market Cap
7.19M
Enterprise Value
10.41M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.11
Market Cap Chart
Since November 26, 1997, Nymox Pharmaceutical's market cap has decreased from 118.04M to 7.19M, a decrease of -93.91%. That is a compound annual growth rate of -9.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 24, 2026 | 7.19M | 75.37% |
| Dec 31, 2025 | 4.10M | -56.61% |
| Dec 31, 2024 | 9.45M | -82.82% |
| Dec 29, 2023 | 55.03M | 86.49% |
| Dec 30, 2022 | 29.51M | -73.23% |
| Dec 31, 2021 | 110.23M | -42.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Brainstorm Cell Therapeutics | 10.04M |
| Synlogic | 8.20M |
| TRON Group | 8.18M |
| NKGen Biotech | 7.84M |
| AccuStem Sciences | 7.71M |
| BetterLife Pharma | 7.11M |
| Bioxytran | 6.53M |
| Mosaic ImmunoEngineering | 5.01M |